U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Project Lead Statistician

Quantitative Biology & BiostatisticsUpdated on Nov 14
Full-timeNo salary listed

About the Job

Requirements

  • A PhD in Biostatistics, Statistics, or equivalent, with 10 or more years of pharmaceutical-industry experience; a Master's degree with 12 or more years of experience is also considered.
  • Several years of experience in a management position leading global teams.
  • Extensive experience designing, analyzing, and reporting clinical trials, with strong knowledge of drug development across all phases; experience in multiple therapeutic areas is preferred.
  • Experience applying innovative statistical approaches, simulation, and quantitative decision-making to support development decisions under uncertainty.
  • Proficiency in SAS or R and sample-size and simulation software; experience with CDISC SDTM/ADaM standards and pharmacokinetics/pharmacodynamics is desired.
  • Excellent written and spoken English, and the ability to explain complex statistical ideas clearly to non-experts and senior management.

Responsibilities

  • Set the statistics team's strategy and be accountable for all its deliverables to the wider project team.
  • Work closely with Development and Regulatory leads to guide and influence the overall strategy for compounds.
  • Share strategic input with senior management on quantitative innovation, analytics, program design, and digital transformation.
  • Help transform the statistics operating model and put the UCB Data Strategy into practice with peers across Biometrics and Data Science.
  • Manage people, set objectives, guide careers, and encourage mentoring and continuous learning.
  • Represent UCB internally and externally, and plan resources, budgets, and travel with fellow Project Lead Statisticians.

Desired Qualifications

  • Experience supporting or managing submissions to global health authorities such as FDA, EMA, or PMDA, and participating in regulatory meetings.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs